In a patient with chronic congestive cardiac-failure, all of the following drugs prolong survival except :
**Core Concept**
The management of chronic congestive cardiac failure (CCF) involves the use of various pharmacological agents to improve symptoms and prolong survival. **Angiotensin-converting enzyme inhibitors (ACE inhibitors)**, **beta-blockers**, and **aldosterone antagonists** are key classes of drugs that have been shown to improve outcomes in these patients.
**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the general approach to treating CCF. Drugs like **ACE inhibitors** and **beta-blockers** work by reducing afterload and improving cardiac function, thereby prolonging survival. **Aldosterone antagonists**, such as spironolactone, also play a crucial role in reducing mortality by counteracting the effects of aldosterone.
**Why Each Wrong Option is Incorrect**
**Option A:** Without knowing the specific option, we can't comment on its correctness.
**Option B:** Similarly, without the option, we can't provide a reason.
**Option C:** This option would be incorrect if it were a drug that is known to prolong survival in CCF.
**Option D:** This could potentially be the correct answer if it were a drug that doesn't prolong survival.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that **ACE inhibitors** and **beta-blockers** are cornerstone therapies in CCF management due to their proven benefit in reducing mortality.
**Correct Answer:** Not provided in the query.